Spiro Medical Secures $67 Million Series A Financing to Develop a Neuromodulation System for Asthma
IRVINE, Calif., Jan. 7, 2026 /PRNewswire/ — Spiro Medical, Inc., a Newco established to develop the first of its kind Pulmonary Neuromodulation System (PNM) for the treatment of Asthma announced today the closing of a $67 million Series A equity financing. The…